文献速递淋巴瘤造血干细胞移植与细胞治疗

中高危儿童急性淋巴细胞白血病无颅脑放疗的长期结局:EORTC 58832随机研究

Long-term outcome evaluation of medium/high risk acute lymphoblastic leukaemia children treated with or without cranial radiotherapy in the EORTC 58832 randomized study.
PubMed 文献 · Br J Haematol · 2019-12-13

EORTC 58832非劣效随机研究纳入1983-1989年CNS阴性中高危新发儿童ALL,CR1末随机接受无颅脑放疗(n=92)或放疗(n=84),中位随访20年。

要点

  • 中高危CNS阴性儿童ALL在充分全身和鞘内预防下,CR1可安全省略颅脑放疗
  • 省略CRT与CNS和内分泌晚期不良反应显著下降相关

核心结论

  • 在充分全身和鞘内CNS预防下,CR1中高危CNS阴性儿童ALL可完全省略颅脑放疗而不影响生存,同时减少晚期不良反应。

研究设计与样本

  • EORTC 58832非劣效随机研究(1983-1989年),纳入CNS阴性中高危新发儿童ALL且在晚期强化末达CR1者,随机分为无CRT组(n=92)与CRT标准组(n=84),中位随访20年(范围4-32年)。

主要发现

  • 省略CRT与CNS和内分泌晚期不良反应发生率显著下降相关。

临床怎么用

  • 对于CNS阴性中高危儿童ALL,在保证充分全身和鞘内CNS预防的前提下,CR1可考虑省略颅脑放疗以降低晚期不良反应。

局限性

  • 研究入组年代为1983-1989年,化疗方案与当前临床实践可能存在差异。
  • 样本量较小(无CRT组92例,CRT组84例),部分指标置信区间较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We investigated the long-term outcome, the incidence of second neoplasms (SN) and the rate of late adverse effects (LAE) in children with central nervous system (CNS) negative medium/high-risk de novo acute lymphoblastic leukaemia (ALL), in first complete remission (CR1) at end of late intensification, randomized to receive no cranial radiotherapy (No CRT, n = 92) versus CRT (standard arm, n = 84) in the non-inferiority EORTC 58832 study (1983-1989). Median follow-up was 20 years (range 4-32 years). The 25-year disease-free survival rate (±SE) was 67·4 ± 4·9% without CRT and 70·2 ± 5·0% with CRT. The 25-year incidence of isolated (6·5 ± 2·6% vs. 4·8 ± 2·3%) and any CNS relapse {8·7 ± 2·9% vs. 11·9 ± 3·5%; hazard ratio (HR) 0·71 [95% confidence interval (CI) 0·28-1·79]; test of non-inferiority: P = 0·01} was not increased without CRT. The 25-year SN incidence in CR1 was 7·9 ± 4·6% vs. 11·0 ± 4·2%. The 25-year event-free and overall survival rates were quite similar in both arms [59·5 ± 6·3% vs. 60·5 ± 5·9%, HR 0·94 (95% CI 0·57-1·52), and 78·1 ± 4·3% vs. 78·5 ± 4·5%, HR 1·00 (95% CI 0·53-1·88)]. Omission of CRT was associated with dramatic decrease in CNS and endocrine LAE rates. In conclusion, our data suggest that, with proper systemic and intrathecal CNS prophylaxis, CRT could totally be omitted in CR1 without jeopardizing survival, while decreasing LAE in childhood ALL.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Piette C, Suciu S, Bertrand Y, et al. Long-term outcome evaluation of medium/high risk acute lymphoblastic leukaemia children treated with or without cranial radiotherapy in the EORTC 58832 randomized study. Br J Haematol. 2019. PMID: 31837008. doi:10.1111/bjh.16337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。